Inactive Instrument

Instituto Hermes Pardini S.A.

Equities

PARD3

BRPARDACNOR1

Healthcare Facilities & Services

Instituto Hermes Pardini S.A. acquired APC Laboratorios for BRL 19.5 million.

August 03, 2021

Instituto Hermes Pardini S.A. (BOVESPA:PARD3) acquired APC Laboratorios for BRL 19.5 million on August 4, 2021. Sergio Bronstein from Bronstein, Zilberberg, Chueiri & Potenza Advogados served as a legal advisor for APC Laboratorios. Instituto Hermes Pardini S.A. (BOVESPA:PARD3) completed the acquisition of APC Laboratorios on August 4, 2021.

Latest news about Instituto Hermes Pardini S.A.

Instituto Hermes Pardini S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from S&P Global BMI Index	23-05-02	CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from Brazil Small Cap Index	23-04-28	CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from Brazil Special Corporate Governance Stock Index	23-04-28	CI
Instituto Hermes Pardini S.A.(BOVESPA:PARD3) dropped from Brazil Special Tag Along Stock Index	23-04-28	CI
Fleury S.A. completed the acquisition of Instituto Hermes Pardini S.A. from Pardini family and others.	23-04-27	CI
Transcript : Instituto Hermes Pardini S.A., Q4 2022 Earnings Call, Mar 15, 2023	23-03-14
Instituto Hermes Pardini S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2022	23-03-14	CI
Instituto Hermes Pardini S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2022	23-03-14	CI
Instituto Hermes Pardini S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Instituto Hermes Pardini Seeks Acquisitions	22-11-11	CI
Transcript : Instituto Hermes Pardini S.A., Q3 2022 Earnings Call, Nov 11, 2022	22-11-11
Instituto Hermes Pardini S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-09	CI
Instituto Hermes Pardini S.A. acquired Laboratório Hugo Silviano Brando for BRL 11 million.	22-11-02	CI
Instituto Hermes Pardini S.A. agreed to acquire Laboratório Hugo Silviano Brando for BRL 11 million.	22-11-02	CI
Brazil's Fleury gets green light for capital increase of up to $229 mln	22-10-17	RE
Instituto Hermes Pardini S.A. has signed an agreement to acquire 99% stake in CSV Central Sorológica de Vitória for an enterprise value BRL 17.8 million.	22-09-26	CI
Transcript : Instituto Hermes Pardini S.A., Q2 2022 Earnings Call, Aug 12, 2022	22-08-12
Instituto Hermes Pardini S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-11	CI
Transcript : Fleury S.A., Instituto Hermes Pardini S.A. - M&A Call	22-06-30
Transcript : Fleury S.A., Instituto Hermes Pardini S.A. - M&A Call	22-06-30
Fleury S.A. agreed to acquire Instituto Hermes Pardini S.A. from Pardini family and others for BRL 2.4 billion.	22-06-29	CI
Transcript : Instituto Hermes Pardini S.A., Q1 2022 Earnings Call, May 13, 2022	22-05-13
Instituto Hermes Pardini S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
Instituto Hermes Seeks Acquisitions	22-02-11	CI

Chart Instituto Hermes Pardini S.A.

Duration

Period

More charts

Company Profile

Instituto Hermes Pardini SA is a Brazil-based company engaged in the management of medical laboratories. The Company provides various diagnostic and analytical services, including toxicological examination, clinical blood analysis, veterinary test, cryopreservation, diagnostic imaging, vaccination, deoxyribonucleic acid (DNA) screening test, as well as cardiometabolic examination, among others. The Company operates a number of healthcare units in the states of Minas Gerais and Sao Paulo, Brazil. The Company belongs to the Hermes Pardini Group.

Sector

Healthcare Facilities & Services

More about the company

Sector Medical & Diagnostic Laboratories

	1st Jan change	Capi.
SONIC HEALTHCARE LIMITED	-21.01%	8.05B
RADNET, INC.	+68.16%	4.32B
DR. LAL PATHLABS LIMITED	+6.69%	2.74B
SYNLAB AG	-2.98%	2.6B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-50.95%	1.97B
NEOGENOMICS, INC.	-18.54%	1.68B
FLEURY S.A.	-21.29%	1.45B
METROPOLIS HEALTHCARE LIMITED	+16.69%	1.2B
DIAN DIAGNOSTICS GROUP CO.,LTD.	-44.86%	1.12B

Medical & Diagnostic Laboratories